Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Aug 2022 for CinCor Pharma, Inc., €3.9M. Read the official filing
Filing timeline
BuySaleSofinnova Partners SAS
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sofinnova Partners SAS: trading record in brief
All filings by Sofinnova Partners SAS on record concern CinCor Pharma, Inc. The record holds 2 filings, for trades running from 11 January 2022 to 15 August 2022.
The open-market record is one-sided, with 1 purchase worth €3.9M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 17 August 2022 with an open-market purchase (€3.9M) in CinCor Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sofinnova Partners SAS
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
133,333 shares@ US$30.00100.0% of flowCommon StockSEC:0001209191-22-046250:0
Canonical exit: 13 Nov 2022 (T+90)
3,867,646 sharesCommon StockSEC:0001209191-22-003195:0
2 of 2 declarations
